1,184,838 after-hours for FCG.AX Freedom Care on ASX 12 Mar 2026: watch

A large after-hours volume spike pushed FCG.AX stock into focus tonight. Volume hit 1,184,838 shares versus an average of 30,060, a 39.42x relative surge that can precede price moves. The price printed A$0.037 (last trade) after an intraday high of A$0.059. We review why this volume matters, what the numbers say about valuation, and where analysts and Meyka AI see the stock headed in the ASX healthcare sector.

FCG.AX stock: after-hours volume snapshot and immediate market reaction

Trade volume spiked to 1,184,838 shares in after-hours on 12 Mar 2026, versus an average daily volume of 30,060.00. The stock opened at A$0.059 and closed at A$0.037, with day high A$0.059 and day low A$0.037. A jump in volume of this size often signals informed orders or block trades that warrant closer monitoring for follow-through during the next ASX session.

Why this volume spike matters for FCG.AX stock trading signals

A large volume surge increases liquidity and can validate directional moves. For FCG.AX stock, the relVolume is 39.42, suggesting the move was much larger than routine flows. When volume outstrips average by this margin, traders watch for sustained price confirmation on higher volume. Volume without price follow-through may indicate short-term interest or distribution.

FCG.AX stock fundamentals and valuation snapshot

Freedom Care Group Holdings Ltd (FCG.AX) reports a market cap of A$4,007,738.00, shares outstanding 108,317,248.00, EPS A$0.01, and PE ratio 3.70. Price-to-sales is 0.21 and price-to-book is 0.75. The company operates in the ASX healthcare sector under Medical – Care Facilities with 290 employees and NDIS services nationwide. These metrics show low market valuation versus peers, but margins and cash flow must be tracked closely.

Meyka AI rates FCG.AX with a score out of 100 and model forecast

Meyka AI rates FCG.AX with a score out of 100: 69.87 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month target of A$0.12, compared with the current A$0.037, implying an upside of 224.32%. Forecasts are model-based projections and not guarantees.

FCG.AX stock technical levels and price targets

Key near-term levels to watch: support at A$0.037, a near-term resistance band at A$0.06–A$0.09, and a medium-term target at A$0.12 per the Meyka model. A conservative short-term trader target is A$0.05 and a bear-case floor is A$0.03. Volume confirmation above 300,000 shares on the next session would strengthen any breakout thesis.

Risks, catalysts and sector context for FCG.AX stock

Key risks include liquidity volatility, operating margins under pressure, and reliance on NDIS funding. Interest coverage and operating margin metrics show strain despite positive net income metrics. Sector peers in Healthcare have stronger average PE ratios near 27.84, so FCG.AX stock carries higher relative operational risk. Short-term catalysts include contract wins, NDIS policy updates, and follow-through volume. For news and peer comparison, see market reporting Investing.com and macro context at Seeking Alpha.

Final Thoughts

The after-hours volume spike of 1,184,838 shares on 12 Mar 2026 puts FCG.AX stock squarely on watch lists. The company trades at A$0.037 with attractive valuation ratios such as PE 3.70 and P/S 0.21, but low liquidity and margin volatility raise near-term risk. Meyka AI’s model projects a 12-month target of A$0.12, implying 224.32% upside from the current price, while a conservative near-term target is A$0.05. Investors should require follow-through volume in the regular ASX session and clearer operational catalysts before increasing exposure. Our Meyka grade is B (69.87), signalling a HOLD stance based on peer comparison, financial metrics, and forecast uncertainty. Use position sizing to manage liquidity risk and track NDIS-related news and company updates. For the live quote and deeper metrics visit the Meyka stock page for FCG.AX.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.